Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

TRO-19622: clinical candidate for motor neuron disease

April 11, 2006

Affiris closes EUR 8.5 million financing round

April 11, 2006

SUVN-501 elevates hippocampal levels of acetylcholine as a potential procognitive treatment

April 11, 2006

Interim phase I results reported for AAV-GAD gene therapy for Parkinson's disease

April 10, 2006

New PARG inhibitors for the treatment of Parkinson's disease identified

April 10, 2006

Pramipexole approved in Europe for restless legs syndrome

April 10, 2006

Daytrana approved for use in ADHD

April 10, 2006

ReNeuron to raise fund through international placing

April 10, 2006

New analgesic agents reported in recent patent literature

April 7, 2006

Recent patents cover therapeutic agents for neurological disorders

April 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...